We are live on ! Find out more
RSSS icon

Research Solutions

2.09 USD
+0.03
1.46%
At close Updated Sep 17, 4:00 PM EDT
1 day
1.46%
5 days
-2.79%
1 month
-9.52%
3 months
-6.7%
6 months
-11.06%
Year to date
-28.67%
1 year
-43.51%
5 years
-21.43%
10 years
-17.39%
 

About: Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from the cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.

Employees: 141

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 11.1%
Neutral 66.7%
Negative 22.2%
Neutral
PRNewsWire
1 day ago
Research Solutions Launches Article Galaxy Plugin In The ChatGPT Plugin Directory, Bringing Rights-Cleared Article Access To AI Research Workflows
Researchers Can Now Check Article Availability, Confirm Access & Reuse Rights, & Order Scientific Literature Through Their Article Galaxy Account Within The ChatGPT Conversation HENDERSON, Nev., Sept. 16, 2026 /PRNewswire/ -- Research Solutions (NASDAQ: RSSS), a leading provider of AI-powered scientific research tools, announces the availability of Article Galaxy as a ChatGPT plugin.
Research Solutions Launches Article Galaxy Plugin In The ChatGPT Plugin Directory, Bringing Rights-Cleared Article Access To AI Research Workflows
Neutral
Seeking Alpha
8 days ago
Research Solutions, Inc. (RSSS) Q4 2026 Earnings Call Transcript
Research Solutions, Inc. (RSSS) Q4 2026 Earnings Call Transcript
Research Solutions, Inc. (RSSS) Q4 2026 Earnings Call Transcript
Negative
Zacks Investment Research
8 days ago
Research Solutions Inc. (RSSS) Misses Q4 Earnings Estimates
Research Solutions Inc. (RSSS) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.
Research Solutions Inc. (RSSS) Misses Q4 Earnings Estimates
Neutral
MarketBeat
8 days ago
Research Solutions Q4 Earnings Call Highlights
Research Solutions NASDAQ: RSSS reported fiscal fourth-quarter revenue of $12.1 million for the period ended June 30, 2026, down from $12.4 million a year earlier, as growth in platform subscriptions was offset by lower transaction revenue. For the full fiscal year, revenue declined to $48.3 million from $49.1 million, while net income and adjusted EBITDA increased.
Research Solutions Q4 Earnings Call Highlights
Neutral
PRNewsWire
8 days ago
Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results
Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research Solutions, Inc.  (NASDAQ: RSSS), the leading AI-powered research workflow platform, reported financial results for its fourth quarter and full fiscal year ended June 30, 2026.
Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results
Neutral
PRNewsWire
16 days ago
Research Solutions to Announce Fourth Quarter and Fiscal Year 2026 Results on Wednesday, September 9, 2026
HENDERSON, Nev., Sept. 1, 2026 /PRNewswire/ -- Research Solutions, Inc.  (NASDAQ: RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results for the fourth quarter and fiscal year 2026 ended June 30, 2026, on Wednesday, September 9, 2026, at 5:00 p.m.
Research Solutions to Announce Fourth Quarter and Fiscal Year 2026 Results on Wednesday, September 9, 2026
Positive
MarketBeat
19 days ago
Research Solutions Targets AI-Driven Growth as High-Margin SaaS Revenue Rises
Research Solutions NASDAQ: RSSS outlined its strategy to expand its scientific research platform through artificial intelligence integrations, while continuing a multiyear shift toward higher-margin subscription software revenue.
Research Solutions Targets AI-Driven Growth as High-Margin SaaS Revenue Rises
Neutral
PRNewsWire
1 month ago
Research Solutions to Participate at Upcoming Investor Conferences
HENDERSON, Nev., Aug. 18, 2026 /PRNewswire/ -- Research Solutions (RSSS) today announced management will participate at the following investor conferences: Midwest IDEAS Conference August 27Location: Chicago, ILThe company will present Thursday, August 27th at 9:55am CT with 1x1 meetings throughout the day, The presentation is webcast and can be accessed at https://www.threepartadvisors.com/midwest Lake Street Capital Markets Big10 Conference September 10Location: New York, NYThe company will host 1x1 meetings throughout the day Qualified investors interested in attending or scheduling a meeting at either conference should contact Lacey Wesley at (817) 769 -2373 or [email protected] or their Lake Street sales representative.
Research Solutions to Participate at Upcoming Investor Conferences
Negative
The Motley Fool
2 months ago
The Russell 2000 Just Did Something for the First Time Since 1991. Here's Why Investors Should Pay Attention.
The Russell 2000 has now lagged the broader market for many years. Small-cap stocks tend to perform well during periods of lower interest rates and economic expansion.
The Russell 2000 Just Did Something for the First Time Since 1991. Here's Why Investors Should Pay Attention.
Neutral
Business Wire
3 months ago
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc. today announced an upsized Series E round of financing, including $175 million from longstanding investor Samsung Electronics, and an undisclosed amount from other investors. The funding will accelerate commercialization of Element's growing ecosystem of genomic and multiomic solutions, expand its global presence, and advance its product roadmap across research, translational science, and diagnostic applications. This new capital will suppor.
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions
Price charts implemented using Lightweight Charts™